NCT01939561View on ClinicalTrials.gov

Lamotrigine as Treatment of Myotonia

PHASE3CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Dystrophia Myotonica Type 1Myotonia CongenitaParamyotonia CongenitaHyperkalemic Periodic ParalysisPotassium-Aggravated Myotonia
Interventions
DRUG

Lamotrigine

DRUG

Placebo

Placebo is tablets identically with the Lamotrigine tablets.

Trial Locations (1)

DK-2100

Copenhagen Neuromuscular Center, department of Neurology, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Grete Andersen, MD

OTHER

NCT01939561 - Lamotrigine as Treatment of Myotonia | Biotech Hunter | Biotech Hunter